Login
$OPCH
$31.71 +$0.06 (0.19%) Live

$OPCH SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
12 Nov 2026 Form 4: Pate R Carter, Director

Sold 6,092 shares ($193K) · Sold 400 shares ($12.7K)

10 Nov 2026 144
09 Nov 2026 DEFM14A
04 Nov 2026 10-Q
04 Nov 2026 8-K: Results of Operations and Financial Condition

BANNOCKBURN, IL., November 4, 2026 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial resul...

28 Oct 2026 PREM14A
27 Oct 2026 SCHEDULE 13G/A
06 Oct 2026 DEFA14A
06 Oct 2026 DEFA14A
06 Oct 2026 8-K: Entry into a Material Definitive Agreement; Regulation FD Disclosure

Exhibit A Form of Certificate of Incorporation of the Surviving Corporation

14 Aug 2026 SCHEDULE 13G/A
29 Jul 2026 10-Q
29 Jul 2026 8-K: Results of Operations and Financial Condition

BANNOCKBURN, IL., July 29, 2026 - Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today financial results ...

08 Jul 2026 Form 4: Bhatia Prateek, EVP Sp Sales & Solutions

Received 39,795 shares as a grant or award

08 Jul 2026 Form 3: Bhatia Prateek, EVP Sp Sales & Solutions

No securities owned

22 May 2026 Form 4: Bierbower Elizabeth D, Director

Received 8,997 shares as a grant or award

22 May 2026 Form 4: Deckmann Natasha, Director

Received 9,841 shares as a grant or award

22 May 2026 Form 4: Kraemer Harry M Jansen Jr, Director

Received 21,076 shares as a grant or award

22 May 2026 Form 4: Pate R Carter, Director

Received 8,997 shares as a grant or award

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support